Abstract
Pregnancy may be associated with ocular changes, which most often are transient in nature. It can exacerbate preexisting conditions or be associated with development of new conditions. The ocular effects of pregnancy may be divided into physiologic changes, pathologic conditions, or modifications of preexisting conditions. Pathologic conditions include entities such as preeclampsia and eclampsia, along with conditions that are seen with increased frequency during pregnancy such as central serous chorioretinopathy. The most significant modified preexisting condition is diabetes mellitus. The various effects of pregnancy on the eye will be reviewed throughout this chapter.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sunness JS. The pregnant woman’s eye. Surv Ophthalmol. 1988;32:219–38.
Philips CI, Gore SM. Ocular hypotensive effect of late pregnancy with and without high blood pressure. Br J Ophthalmol. 1985;69:117–9.
Paterson GL, Miller SJH. Hormonal influences in simple glaucoma. Br J Ophthalmol. 1963;47:129–37.
Wilke L. Episcleral venous pressure and pregnancy. Acta Ophthalmol (Copen). 1975;125(Suppl):40–41.
Horven I, Gjonnaess H, Kroese A. Corneal indentation pulse and intraocular pressure in pregnancy. Arch Ophthalmol. 1974;91:92–8.
Riss B, Riss P. Corneal sensitivity in pregnancy. Ophthalmologica. 1981;183:57–62.
Weinreb RN, Lu A, Beeson C. Maternal corneal thickness during pregnancy. Am J Ophthalmol. 1988;105: 258–60.
Park SB, Lindahl KJ, Temnycky GO, Aquavella JV. The effect of pregnancy on the corneal curvature. CLAO J. 1992;18:256–9.
Millodot M. The influence of pregnancy on the sensitivity of the cornea. Br J Ophthalmol. 1977;61: 646–9.
Fatt I, Harris MG. Refractive index of the cornea as a function of its thickness. Am J Optom Physiol Opt. 1973;50:383–6.
Schreyer P, Tzadok J, Sherman DJ, et al. Fluorescein angiography in hypertensive pregnancies. Int J Gynecol Obstet. 1990;34:127–32.
Jaffe G, Schatz H. Ocular manifestations of preeclampsia. Am J Ophthalmol. 1987;103:309–15.
Fry WE. Extensive bilateral retinal detachment in eclampsia with complete reattachment. Arch Ophthalmol. 1929;1:609–14.
Hallum AV. Eye changes in hypertensive toxemia of pregnancy. JAMA. 1936;106:1649–51.
Valluri S, Adelberg D, Curtis R, et al. Diagnostic indocyanine green angiography in preeclampsia. Am J Ophthalmol. 1996;122:672–7.
Saito Y, Tano Y. Retinal pigment epithelial lesions associated with choroidal ischemia in preeclampsia. Retina. 1998;18:103–8.
Fry WE. Extensive bilateral retinal detachment in eclapmsia with complete retinal detachment. Arch Ophthalmol. 1929;1:609–614.
Beck RW, Gamel JW, Willcourt RJ, Berman G. Acute ischemic optic neuropathy in severe preeclampsia. Am J Ophthalmol. 1980;90:342–6.
Grimes DA, Ekbladh LE, McCartney WH. Cortical blindness in preeclampsia. Int J Gynaecol Obstet. 1980;17:601–3.
Beeson JH, Duda EE. Computed axial tomography scan demonstration of cerebral edema in eclampsia preceded by blindness. Obstet Gynecol. 1982;60:529–32.
Gupta LY, Mansour SE. Bilateral bullous retinal detachment as a complication of the HELLP syndrome. Can J Ophthalmol. 1994;29:242–5.
Leff SR, Yarian DL, Masciulli L, et al. Vitreous haemorrhage as a complication of HELLP syndrome. Br J Ophthalmol. 1990;74:498–9.
Cunningham FG, MacDonald PC, Gant NF, et al. Hypertensive disorders in pregnancy. In: Williams obstetrics. 19th ed. Norwalk: Appleton & Lange; 1993. p. 764–5.
Sunness JS, Haller JA, Fine SL. Central serous retinopathy and pregnancy. Arch Ophthalmol. 1993;111:360–4.
Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Am J Ophthalmol. 1974;77:158–60.
Fastenberg DM, Ober RR. Central serous choroidopathy in pregnancy. Arch Ophthalmol. 1983;101:1055–8.
Gass JDM. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol. 1991;109:677–81.
Blodi BA, Johnson MW, Gass JDM, et al. Purtscher’s-like retinopathy after childbirth. Ophthalmology. 1990;97:1654–959.
Cogan D. Ocular involvement in disseminated intravascular coagulopathy. Arch Ophthalmol. 1975;93:1–8.
Hoines J, Buettner H. Ocular complications of disseminated intravascular coagulation (DIC) in abruptio placenta. Retina. 1989;9:105–9.
Amarosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine. 1962;45:139–59.
Percival SP. The eye and Moschcowitz’s disease (thrombotic thrombocytopenic purpura): a review of 182 cases. Trans Ophthalmol Soc UK. 1970;90:375–82.
Lewellen DR, Singerman LJ. Thrombotic thrombocytopenic purpura with optic disk neovascularization, vitreous hemorrhage, retinal detachment, and optic atrophy. Am J Ophthalmol. 1980;89:840–4.
Gum KB, Carter KD, Vine AK. Massive bilateral retinal vascular occlusion secondary to thrombocytopenic purpura. Retina. 1988;8:185–7.
Power MH, Regillo MC, Custis PH. Thrombotic thrombocytopenic purpura associated with purtscher retinopathy. Arch Ophthalmol. 1997;115:128–9.
Chang M, Herbert W. Retinal arteriolar occlusions following amniotic fluid embolism. Ophthalmology. 1984;91:1634–7.
Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13:34–40.
Axer-Seigel R, Hod M, Fink-Cohen S, et al. Diabetic retinopathy during pregnancy. Ophthalmology. 1996;103:1815–9.
Phelps RL, Sakol P, Metzger BE, et al. Changes in diabetic retinopathy during pregnancy. Arch Ophthalmol. 1986;104:1806–10.
Moloney JB, Drury MI. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol. 1982;93:745–56.
Best RM, Chakravarthy U. Diabetic retinopathy in pregnancy. Br J Ophthalmol. 1997;81:249–51.
Sinclair SH, Nesler C, Foxman B, et al. Macular edema and pregnancy in insulin-dependent diabetes. Am J Ophthalmol. 1984;97:154–67.
Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. Diabetes Care. 1995;18:631–7.
Lauszus F, Klebe JG, Bek T. Diabetic retinopathy in pregnancy during tight metabolic control. Acta Obstet Gynecol Scand. 2000;79:367–70.
Sinclair SH, Nesler CL, Schwartz SS. Retinopathy in the pregnant diabetic. Clin Obstet Gynecol. 1985;28:536–52.
Kitzmiller JL, Main E, Ward B, et al. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care. 1999;22:874–6.
Chen HC, Newsom RS, Patel V, et al. Retinal blood flow changes during pregnancy in women with diabetes. Invest Ophthalmol Vis Sci. 1994;35:3199–208.
Schocket LS, Grunwald JE, Tsang AF, et al. The effects of pregnancy on retinal hemodynamics in diabetic versus nondiabetic mothers. Am J Ophthalmol. 1999;128:477–84.
The Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. Arch Ophthalmol. 1979;97:654–5.
Stoessel KM, Liao PM, Thompson JT, Reece AE. Diabetic retinopathy and macular edema in pregnancy. Ophthalmology. 1991;98(suppl):146.
The American Academy of Ophthalmology. Diabetic retinopathy. Preferred practice patterns, vol. 13. San Francisco: The American Academy of Ophthalmology; 1998. p. 28.
Siegel R, Ainslie WH. Malignant ocular melanoma during pregnancy. JAMA. 1963;185:542–3.
Seddon JM, MacLaughlin DT, Albert DM, et al. Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas. Br J Ophthalmol. 1982;66:695–704.
Shields C, Shields J, Eagle R, et al. Uveal melanoma and pregnancy. Ophthalmology. 1991;98:1667–73.
McLeod BK. Choroidal osteoma presenting during pregnancy. Br J Ophthalmol. 1988;72:612–4.
Gass JDM. Stereoscopic atlas of macular diseases: a funduscopic and angiographic presentation. 4th ed. St. Louis: CV Mosby; 1997. p. 218–9.
Pitta C, Bergen R, Littwin S. Spontaneous regression of a choroidal hemangioma following pregnancy. Am J Ophthalmol. 1979;11:772–4.
Sunness JS. Pregnancy and the eye. Ophthalmol Clin North Am. 1992;5:623–40.
Samples JR, Meyer SM. Use of ophthalmic medications in pregnant and nursing women. Am J Ophthalmol. 1988;106:616–23.
Blaul G. Lokale betablocker wahrend der graviditat. Klin Monbl Augenheilkd. 1981;179:128–9.
Lustgarten JS, Podos SM. Topical timolol and the nursing mother. Arch Ophthalmol. 1983;101:1381.
Mattern J, Mayer PR. Excretion of fluorescein into breast milk. Am J Ophthalmol. 1990;109:598–9.
McEnerney JK, Wong WP, Peyman GA. Evaluation of the teratogenicity of fluorescein sodium. Am J Ophthalmol. 1977;84:847–50.
Salem H, Loux JJ, Smith S, Nichols CW. Evaluation of the toxicologic and teratogenic potentials of sodium fluorescein in the rat. Toxicology. 1979;12:143–50.
Halperin LS, Olk RJ, Soubrane G, Coscas G. Safety of fluorescein angiography during pregnancy. Am J Ophthalmol. 1990;109:563–6.
Rudolf H, Goretzlehner G, Brugmann E, et al. Assessment of liver function using indocyanine green (Ujoviridin) during normal pregnancy, during labor and in puerperium (in German). Zentralbl Gynakol. 1977;99:1548–53.
Fineman MS, Maguire JI, Fineman SW, Benson WE. Safety of indocyanine green angiography during pregnancy. Arch Ophthalmol. 2001;119:353–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kuhl, D., Schwartz, S.G., Sheth, B.P., Mieler, W.F. (2013). Ocular Manifestations of Pregnancy. In: Arévalo, J. (eds) Retinal and Choroidal Manifestations of Selected Systemic Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3646-1_25
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3646-1_25
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3645-4
Online ISBN: 978-1-4614-3646-1
eBook Packages: MedicineMedicine (R0)